Back

Unicycive faces class-action lawsuit over alleged disclosures during December 2025-June 2026

Verifying
  • Bragar Eagel & Squire filed a class-action lawsuit against Unicycive Therapeutics.
  • The class period runs from Dec. 29, 2025, through June 29, 2026.
  • Investors have until Nov. 2, 2026, to seek lead-plaintiff appointment.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.